Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 27, 2004

View Archived Issues

Enhancement of memory T-cells may improve vaccine therapies

New approvals for tamsulosin formulations

Promising results with small molecule MIF inhibitors in a preclinical model of colitis

Taiho patent covers new antiarthritic agents

Novel HDL-increasing agents developed at Eisai

Novel PDE4 inhibitors prepared and tested at Kyowa Hakko

Oxazepine-based antitumor agents newly discovered at Servier

Novel DPP-IV inhibitors and their use in type 2 diabetes claimed by Merck

New antitumor, antibacterial and antifungal agents isolated from Streptomyces sp.

Pfizer researchers describe new cannabinoid CB1 antagonists

Micrologix Biotech changes name to Migenix

Introgen Therapeutics receives NCI grant to further mda-7 gene research

Ceregene begins phase I trial of novel gene therapy for Alzheimer's disease

GSK grants Kenyan company license for manufacture and sale of HIV/AIDS medicines in Africa

Pharmion's MAA for Vidaza accepted for review by EMEA

Good safety profile reported for the NYVAC-HIVC vaccine in healthy volunteers

Phase II trial of Infecton for the detection of bacterial osteomyelitis initiated

Therapeutic benefits of SomatoKine in a child with Leprechaunism

E.U. approves Xenical label change

Clinical evidence for the efficacy of topiramate in the prevention of migraine

CytoVax and Millenium enter into definitive merger agreement

Phase I study for novel antibiotic WAP-8294A2 commences in U.S.

Fast track designation for Aurexis

FDA grants priority review to investigational female testosterone patch

Roche and Glycart to discover next-generation therapeutic antibodies

Enrollment completed for U.S. phase II Psoraxine study

GW-274150 reduces experimental neuropathic hypersensitivity

In vivo effects of capsaicin reduced by GW-833972

AF-3191 effective in preclinical pain models

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...